Immunome, Inc. · NASDAQ:IMNM
T. Rowe Price Investment Management, Inc. reported a 14.50% stake in Immunome, Inc. (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
T. Rowe Price Investment Management, Inc. reported a 14.50% stake in Immunome, Inc., 16,364,011 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 14.50%
- Shares
- 16,364,011
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| T. Rowe Price Investment Management, Inc. | 14.50% | 16,364,011 |
Source
Related
- Immunome, Inc.
- T. Rowe Price Investment Management, Inc.
- Immunome, Inc. shareholders
- Schedule 13G/A · T. Rowe Price Investment Management, Inc. · Aug 14, 2026
- Schedule 13G · T. Rowe Price Investment Management, Inc. · Nov 7, 2025
- Form 4 · Higgins Jack · Sep 15, 2026
- Schedule 13G/A · Sirenia Capital Management LP · Aug 14, 2026
- Form 4 · Barchas Isaac · Aug 12, 2026
- Form 4 · Barchas Isaac · Aug 10, 2026
- Form 4 · Horn Kinney · Aug 6, 2026